In-office work at highest level since 2020, as companies pull back on remote
I remember getting drinks after work in 2021, and it still felt like you were human furniture in a way. Now, it feels like ...
Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
Q4 2024 Management View CEO Ryan Spencer highlighted the company’s record HEPLISAV-B product revenue in Q4 and 2024, achieving profitability and implementing a share repurchase plan. Looking ahead, ...